These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9550091)

  • 41. Discovery of novel 2,8-diazaspiro[4.5]decanes as orally active glycoprotein IIb-IIIa antagonists.
    Mehrotra MM; Heath JA; Smyth MS; Pandey A; Rose JW; Seroogy JM; Volkots DL; Nannizzi-Alaimo L; Park GL; Lambing JL; Hollenbach SJ; Scarborough RM
    J Med Chem; 2004 Apr; 47(8):2037-61. PubMed ID: 15056002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists.
    Yu Y; Dwyer MP; Chao J; Aki C; Chao J; Purakkattle B; Rindgen D; Bond R; Mayer-Ezel R; Jakway J; Qiu H; Hipkin RW; Fossetta J; Gonsiorek W; Bian H; Fan X; Terminelli C; Fine J; Lundell D; Merritt JR; He Z; Lai G; Wu M; Taveras A
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1318-22. PubMed ID: 18242983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis, physicochemical and anticonvulsant properties of N-benzyl and N-aminophenyl derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Part I.
    Obniska J; Dzierzawska-Majewska A; Zagorska A; Zajdel P; Karolak-Wojciechowska J
    Farmaco; 2005; 60(6-7):529-39. PubMed ID: 15950973
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
    Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
    Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New antithrombotics with an indazole structure.
    Yildiz AK; Rehse K; Stasch JP; Bischoff E
    Arch Pharm (Weinheim); 2004 Jun; 337(6):311-6. PubMed ID: 15188220
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis and structure-activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists.
    Lai G; Merritt JR; He Z; Feng D; Chao J; Czarniecki MF; Rokosz LL; Stauffer TM; Rindgen D; Taveras AG
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1864-8. PubMed ID: 18304809
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New class of potent antinociceptive and antiplatelet 10H-phenothiazine-1-acylhydrazone derivatives.
    Silva GA; Costa LM; Brito FC; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2004 Jun; 12(12):3149-58. PubMed ID: 15158783
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo effect of chloroquine on platelet aggregation in anesthetized rats.
    Osim E; Mudzudzu B; Musabayane CT; Coutts A
    Haematologica; 1999 Jan; 84(1):92-3. PubMed ID: 10232936
    [No Abstract]   [Full Text] [Related]  

  • 50. Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives.
    Chen HS; Kuo SC; Teng CM; Lee FY; Wang JP; Lee YC; Kuo CW; Huang CC; Wu CC; Huang LJ
    Bioorg Med Chem; 2008 Feb; 16(3):1262-78. PubMed ID: 17988878
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and anticonvulsant properties of a series of N-substituted 2-aza-spiro[4.5]decane-1,3-diones and 8-phenyl-2-aza-spiro[4.5]decane-1,3-diones.
    Obniska J
    Acta Pol Pharm; 2004; 61(6):467-72. PubMed ID: 15794340
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of isoquinoline alkaloids of different structural types on antiplatelet aggregation in vitro.
    Chia YC; Chang FR; Wu CC; Teng CM; Chen KS; Wu YC
    Planta Med; 2006 Oct; 72(13):1238-41. PubMed ID: 16981134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of glyoxalase I by new squaric acid derivatives.
    Kraus JL; Castaing M
    Res Commun Chem Pathol Pharmacol; 1989 Mar; 63(3):467-70. PubMed ID: 2727397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and pharmacological evaluation of a new class of 2-oxo-8-azaspiro (4,5)decan-1-ones as analogues of the muscarinic agonist RS-86.
    Cignarella G; Villa S; Barlocco D
    Farmaco; 1993 Oct; 48(10):1439-45. PubMed ID: 8117382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and pharmacological evaluation of 5,6-dihydrobenzo[f] cinnolin-2(3H)ones analogues of antihypertensive and antiaggregating benzo[h]cinnolinones.
    Pinna GA; Curzu MM; Fraghì P; Gavini E; D'Amico M
    Farmaco; 1996 Oct; 51(10):653-8. PubMed ID: 8981755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Studies on pyrazine derivatives. XXX. Synthesis of pyrazinylamino-1,3-diazacycloalkanes of potential circulatory activity.
    Foks H; Wisterowicz K; Damasiewicz B; Nasal A; Petrusewicz J; Radwańska A
    Acta Pol Pharm; 1997; 54(1):55-62. PubMed ID: 9415199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis, in vitro antiplatelet activity and molecular modelling studies of 10-substituted 2-(1-piperazinyl)pyrimido[1,2-a]benzimidazol-4(10H)-ones.
    Di Braccio M; Grossi G; Signorello MG; Leoncini G; Cichero E; Fossa P; Alfei S; Damonte G
    Eur J Med Chem; 2013 Apr; 62():564-78. PubMed ID: 23425969
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 7-Substituted theophyllines. Part VI--N-[2-(4-chlorophenoxy)-1-phenyl-alkyl]-alkylamido derivatives.
    Diamantini G; Spadoni G; Salvatori A; Duranti E; Pescador R
    Farmaco; 1990 Jun; 45(6):665-72. PubMed ID: 2271074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereocontrolled synthesis of spiro[n.2]alkenes by ring contraction of fused-cyclobutanols.
    Takasu K; Nagamoto Y; Takemoto Y
    Chemistry; 2010 Jul; 16(28):8427-32. PubMed ID: 20549753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis and in vitro stability of nucleoside 5'-phosphonate derivatives.
    Vertuani S; Baldisserotto A; Varani K; Borea PA; De Marcos Maria Cruz B; Ferraro L; Manfredini S; Dalpiaz A
    Eur J Med Chem; 2012 Aug; 54():202-9. PubMed ID: 22705000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.